Evidence map›Paper›PMID 41875159›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Unique structural and ligand-binding properties of the

Jeyun Jo, Tulsi Upadhyay, Xiangyan You, John M Bennett, Hyunbin Lee, Matthew Bogyo, Matthias Fellner

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jeyun Jo *Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305.ORCID 0000-0002-6701-0452
Tulsi UpadhyayDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305.
Xiangyan YouDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.
John M BennettDepartment of Chemistry, Stanford University, Stanford, CA 94305.ORCID 0000-0001-7537-7564
Hyunbin LeeDepartment of Biochemistry, Stanford University, Stanford, CA 94305.ORCID 0009-0006-1911-435X
Matthew BogyoDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305.ORCID 0000-0003-3753-4412
Matthias Fellner *Department of Biochemistry, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0003-3192-6984

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Staphylococcus serine hydrolases as targets for therapeutic and imaging contrast agentsR01EB026332 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2018 to 2021
$1.4M
NIBIB NIH HHS R01 EB026332NIGMS NIH HHS R01 GM129325Royal Society of New Zealand | Marsden Fund (Royal Society of New Zealand Marsden Fund) General grant
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial ProteinsHydrolasesStaphylococcus aureusCatalytic DomainCrystallography, X-RayLigandsModels, MolecularProtein BindingProtein ConformationSubstrate SpecificityBacterial ProteinsHydrolasesLigandscovalent inhibitorserine hydrolaseStaphylococcus aureusstructural biology

Identifiers

PMID41875159
PMCPMC13037872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.